ヘルスケア分析試験サービスの世界市場-2023年～2030年

市場概要

ヘルスケア分析試験サービスの世界市場は、2022年に64億米ドルに達し、2030年には147億米ドルに達するなど、有利な成長が予測されています。ヘルスケア分析試験サービスの世界市場は、予測期間中（2023-2030年）に11.1%のCAGRを示すと予測されています。

ヘルスケア分析試験サービスは、潜在的なリスクを特定し、医療機器、医薬品、その他のヘルスケア製品の品質と有効性を確保するための試験を実施することで、患者の安全を守るのに役立つ。これらの検査は、汚染物質を特定し、製品の完全性を検証し、患者に脅威を与える可能性のある有害物質を検出するのに役立つ。

検査サービスは、さまざまな治療方法の有効性の評価に貢献します。臨床試験や研究は、治療成績の測定、体内の薬物濃度の評価、疾患の進行や治療反応のバイオマーカーの評価など、分析検査に依存しています。

市場力学

臨床検査サービスのアウトソーシング動向の高まりが市場成長を牽引

検体検査サービスのアウトソーシング動向の高まりを受けて、各社は多様なサービスやソリューションを提供することで市場シェアを拡大しています。また、大手企業はM&Aなどの戦略にも注力しています。

例えば、2021年8月、ユーロフィンズ・サイエンティフィックは、日本における検査サービスの提供範囲を拡大するため、ノーリツ鋼機株式会社と契約を締結しました。バイオ分析検査サービスは極めて重要であるため、市場は急速に拡大すると予想されます。そのため、有力企業の拡大戦略が市場の成長に寄与しています。

感染症の流行増加が市場成長を牽引

デング熱、HIVなどの感染症の有病率の増加が市場成長の原動力となります。例えば、WHOによると、人を刺す蚊に感染するデングウイルス（DENV）は、デング熱として知られるウイルス感染症を引き起こします。現在、世界人口の約半数がデング熱のリスクにさらされており、年間1億～5億人が感染していると考えられています。デング熱は熱帯・亜熱帯の病気で、主に都市部や半都市部で発症します。感染症が増加しているため、ラボで分析する必要があるが、ヘルスケア分析検査サービスの市場は今後数年で拡大すると思われます。

データの安全性が市場成長の妨げに

ヘルスケア分析検査サービスにおけるデータ・インセキュリティへの対応には、強固なサイバーセキュリティ対策、定期的なセキュリティ評価、従業員トレーニング、関連規制の遵守など、多面的なアプローチが必要です。ヘルスケア組織にとって、患者データの保護に投資し、進化するサイバー脅威に直面しても警戒を怠らないことは極めて重要です。したがって、上記の要因は市場の成長を制限します。

COVID-19影響分析

COVID-19パンデミックはヘルスケア分析試験サービスに大きな影響を与えました。検査需要の増加、新しい検査方法と技術の採用の加速、検査室のリソースの逼迫、優先順位の再形成につながっています。パンデミックは、困難にもかかわらず、イノベーションとコラボレーションを促進し、検査手法の進歩とヘルスケア分析検査サービスへの自動化とAIの統合を推進しました。

ロシア・ウクライナ紛争の影響分析

ロシア・ウクライナ紛争は、この地域の主要市場プレーヤーの数が少ないことから、世界のヘルスケア分析試験サービス市場に与える影響は中程度と推定されます。しかし、原材料の輸出入の影響は、予測期間中、世界のヘルスケア分析試験サービス市場の成長にほとんど影響を与えないと予測されます。

人工知能の影響分析

AIを搭載したアルゴリズムは、X線、CTスキャン、MRIなどの医療画像を驚くべき精度で分析することができます。ディープラーニング・アルゴリズムは、人間の専門家では識別が困難な異常、病変、パターンを検出することができます。これにより、放射線科医は正確な診断を下し、エラーを減らし、患者の転帰を改善することができます。AIは、データ分析・解釈から予測分析、画像分析、ゲノム分析、創薬、品質管理、ワークフロー最適化まで、ヘルスケア分析検査サービスにおいて大きな利点を提供します。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 臨床試験の増加が市場成長を牽引
    • バイオ分析検査サービスの増加
  • 抑制要因
    • データの安全性が市場成長の妨げになる
  • 機会
    • 予防ヘルスケアと病気の早期発見への注目の高まり
  • 影響分析

第5章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 人工知能の影響

第8章 検査タイプ別

• バイオ分析試験サービス
• 試験法開発とバリデーション
• 安定性試験
• 医薬品物質
• その他

第9章 エンドユーザー別

• 製薬・バイオ製薬企業
• 医療機器企業
• 受託研究機関
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • その他アジア太平洋地域
• 中東およびアフリカ
  • 主な地域別ダイナミクス

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Pharmaceutical Product Development, LLC（PPD）
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Eurofins Scientific
• SGS SA
• Toxikon Inc.
• Pace Analytical Services
• Intertek Pharmaceutical Services
• Boston Analytical
• West Pharmaceutical Services Inc.
• Steris
• Charles River Laboratories.

第13章 付録

Market Overview

The Global Healthcare Analytical Testing Services Market reached US$ 6.4 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 14.7 billion by 2030. The global Healthcare Analytical Testing Services Market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030).

Healthcare analytical testing services help safeguard patient safety by conducting tests to identify potential risks and ensure the quality and efficacy of medical devices, pharmaceuticals, and other healthcare products. These tests help identify contaminants, verify product integrity, and detect any harmful substances that could pose a threat to patients.

Testing services contribute to evaluating the effectiveness of different treatment modalities. Clinical trials and studies rely on analytical testing to measure treatment outcomes, assess drug concentrations in the body, and evaluate biomarkers of disease progression or treatment response.

Market Dynamics

Rising Trend of Outsourcing Laboratory Testing Services Will Drive The Market Growth

Companies are growing their market share by providing a variety of services and solutions as a result of the rising trend of outsourcing laboratory testing services. Major players are also concentrating on other strategies, including mergers, acquisitions, and other advances.

For instance, in August 2021, to increase the scope of its testing offerings in Japan, Eurofins Scientific entered into a contract with Noritsu Koki Co. Ltd to purchase GeneTech Inc., a major participant in genetic analysis in Japan.The market is expected to increase rapidly since the bioanalytical testing service is crucial. Therefore, prominent players' expanding strategies contribute to the growth of the market.

Increasing Prevalence Of Infectious Diseases Will Drive The Market Growth

The increasing prevalence of infectious diseases like dengue, HIV and others will drive the market growth. For instance, according to WHO, the dengue virus (DENV), which infects mosquitoes that bite people, causes the viral infection known as dengue. Approximately half of the world's population is now at risk for dengue, with 100-500 million infections thought to occur annually. Dengue is a tropical and subtropical disease that primarily affects urban and semi-urban settings. Although it must be analyzed in laboratories since infectious diseases are on the rise, the market for healthcare analytical testing services will expand in the next years.

Data Insecurity Will Hamper The Market Growth.

Addressing data insecurity in healthcare analytical testing services requires a multi-faceted approach involving robust cybersecurity measures, regular security assessments, employee training, and compliance with relevant regulations. It is crucial for healthcare organizations to invest in the protection of patient data and stay vigilant in the face of evolving cyber threats. Thus above factors restrict the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on healthcare analytical testing services. It led to increased testing demand, accelerated the adoption of new testing methods and technologies, strained laboratory resources, and reshaped priorities. Despite the challenges, the pandemic also spurred innovation and collaboration, driving advancements in testing methodologies and the integration of automation and AI into healthcare analytical testing services.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global Healthcare Analytical Testing Services market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global Healthcare Analytical Testing Servicesmarket growth over the forecast period.

Artificial Intelligence Impact Analysis

AI-powered algorithms can analyze medical images, such as X-rays, CT scans, and MRIs, with remarkable precision. Deep learning algorithms can detect anomalies, lesions, and patterns that might be difficult for human experts to identify. This assists radiologists in making accurate diagnoses, reducing errors, and improving patient outcomes. AI offers significant advantages in healthcare analytical testing services, ranging from data analysis and interpretation to predictive analytics, image analysis, genomic analysis, drug discovery, quality control, and workflow optimization.

Segment Analysis

The global healthcare analytical testing servicesmarket is segmented based on test type, end user and region.

Pharmaceutical & Biopharmaceutical Companies from End user Segment Accounts for 38.3% of Market Share.

The strategies of the key players will dominate the segment's growth. For instance, on October 24, 2022, as part of its $97 million expansion, Thermo Fisher added a clinical research facility.

The business establishes a bioanalytical lab in the US, adding 59,000 square feet of additional space to the facility overall, making it "one of the largest laboratories of its kind." The new bioanalytical facility is part of a $97 million (€99 million) total investment that Thermo Fisher will make at the Richmond, Virginia, location. The lab will be utilized to offer laboratory services in the drug development process, the company claims. As a result, market growth will be dominated by key players' company expansion and collaboration.

Geographical Analysis

Asia Pacific Accounted for Approximately 25.4% of the Market Share

Due to increased investments made in improving regional analytical services by businesses from developed economies, changes made to evaluation standards by regulatory bodies to bring them into line with international standards, and the creation of new facilities and alliances to expand the reach of their offerings to different regions in the region.

For instance, on May 19, 2021, Leading global life sciences company announced the addition of bioanalytical services in Singapore to its drug development offering in the Asia-Pacific region. And Singapore is a significant region for bolstering Labcorp's vast global presence because it provides clients of the company with a complementary site to support their bioanalytical research, both domestically and internationally.

Additionally, August 04, 2021, TetraQ has been acquired by Agilex Biolabs as part of its APAC expansion plans. Agilex Biolabs specialises in the bioanalysis of biologics and small compounds for PK, immunogenicity, biomarker, and immunological pharmacodynamics assessments. With its knowledgeable workforce and decades of experience in regulated bioanalytical services, TetraQ complements the work of Agilex Biolabs in Australia and the APAC region. Thus, the aforementioned variables predominate market growth.

Competitive Landscape

The major global players in the healthcare analytical testing services market include: Pharmaceutical Product Development, LLC (PPD), Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc., Steris, Charles River Laboratories and among others.

Why Purchase the Report?

• To visualize the global healthcare analytical testing services market segmentation based on test type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of Healthcare Analytical Testing Services market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global Healthcare Analytical Testing Services market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Test Type
• 3.2. Snippet by End User
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising clinical trials will drive the market growth
    • 4.1.1.2. Increasing growth for bioanalytical testing services
  • 4.1.2. Restraints
    • 4.1.2.1. Data Insecurity will hamper the market growth
  • 4.1.3. Opportunity
    • 4.1.3.1. The increasing focus on preventive healthcare and early disease detection
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Artificial Intelligence Impact

8. ByTest Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  • 8.1.2. Market Attractiveness Index, By Test Type
• 8.2. Bioanalytical Testing Services*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Method Development & Validation
• 8.4. Stability Testing
• 8.5. Drug Substances
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Pharmaceutical & Biopharmaceutical Companies*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Medical Device Companies
• 9.4. Contract Research Organizations
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.5.1. The U.S.
    • 10.2.5.2. Canada
    • 10.2.5.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.5.1. Germany
    • 10.3.5.2. The U.K.
    • 10.3.5.3. France
    • 10.3.5.4. Spain
    • 10.3.5.5. Italy
    • 10.3.5.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.5.1. Brazil
    • 10.4.5.2. Argentina
    • 10.4.5.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.5.1. China
    • 10.5.5.2. India
    • 10.5.5.3. Japan

Australia

• 10.5.5.4. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Pharmaceutical Product Development, LLC (PPD)*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Eurofins Scientific
• 12.3. SGS SA
• 12.4. Toxikon Inc.
• 12.5. Pace Analytical Services
• 12.6. Intertek Pharmaceutical Services
• 12.7. Boston Analytical
• 12.8. West Pharmaceutical Services Inc.
• 12.9. Steris
• 12.10. Charles River Laboratories.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us